| Revenues | | 12.02 | 28.00 | 9.28 | 9.08 |
| | 8.59 | 5.45 | - | - |
| Selling, General, and Administrative | | 8.59 | 5.45 | - | - |
| Research and Development | | 4.01 | 11.50 | - | - |
| Costs And Expenses | | 21.83 | 28.20 | 24.94 | 41.33 |
| Operating Income/Loss | | -9.81 | -0.21 | -15.66 | -32.24 |
| Nonoperating Income/Loss | | -0.32 | 2.65 | 18.67 | 3.08 |
| Income/Loss From Equity Method Investments | | -4.55 | -2.53 | -0.15 | -3.34 |
| Income Tax Expense/Benefit | - | - | - | - | - |
| | -14.68 | -0.08 | 2.86 | -32.50 |
| Attributable To Parent | | -14.68 | -0.08 | 2.86 | -32.50 |
| Basic Average Shares | | 8.27 | - | 2.32 | 218.12 |
| Diluted Average Shares | | 8.27 | - | 2.66 | 218.12 |
| Basic Earnings Per Share | | -1.77 | - | 1.14 | -0.15 |
| Diluted Earnings Per Share | | -1.77 | - | 0.99 | -0.15 |
LNZA
